Dysfunctional Gene May Be Culprit in Some Crohn’s Disease Cases
Scripps Research InstituteThe scientists hope understanding how immune cells adapt as they enter different tissues will spur the design of better, more specific, medicines.
The scientists hope understanding how immune cells adapt as they enter different tissues will spur the design of better, more specific, medicines.
"Eric is an esteemed colleague with a clear vision for integrating scientific discovery and translational medicine."
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have now uncovered new insights into the regulatory network behind neuron growth.
Jeffery Kelly, Ph.D., co-chair of the Department of Molecular Medicine at The Scripps Research Institute (TSRI), has been named a fellow of the esteemed National Academy of Inventors (NAI), the organization announced today.
New research suggests these hidden genes hold the blueprints for designing new, even more effective cancer-targeting compounds.
How do killer T cells “learn” to leave their home base and amass within specific tissues like the skin, gut, and lung, or solid tumors?
A team of researchers from The Scripps Research Institute (TSRI) and Duke University has made the first determination of the atomic structure of Transient Receptor Potential Melastatin 8 (TRPM8), a molecular sensor in nerve ends that detects cold temperatures as well as menthol and other chemicals that induce cold sensations.
Telenti is a leading data scientist and genomic researcher whose research foci include human genomics, as well as infectious disease research.
This “semi-synthetic” strain of E. coli is the first to both contain unnatural bases in its DNA and use the bases to instruct cells to make a new protein.
Understanding how brains actively erase memories may open new understanding of memory loss and aging, and open the possibility of new treatments for neurodegenerative disease.
A new study from The Scripps Research Institute (TSRI) is the first to show precisely how a process in nerve cells called the S-nitrosylation (SNO) reaction—which can be caused by aging, pesticides and pollution—may contribute to Parkinson’s disease.
The research shows that a range of compounds can deliver pain-blocking potency without affecting respiration.
New research could boost the development of a more potent vaccine against the global killer.
NitroSynapsin is intended to restore an electrical signaling imbalance in the brain found in virtually all forms of autism spectrum disorder (ASD).
Celgene Corporation recently announced results from two phase 3 trials evaluating the efficacy and safety of the drug ozanimod. Ozanimod was invented by scientists at The Scripps Research Institute (TSRI).
Chemists at The Scripps Research Institute (TSRI) have found a compound that may have been a crucial factor in the origins of life on Earth.
Egg-based production causes virus to target bird cells, making vaccine less effective.
The MyGeneRank app allows individuals with genetic data from 23andMe to obtain an estimated genetic risk score for coronary artery disease.
Scientists from the Florida campus of The Scripps Research Institute have created a new class of antibody-drug conjugates for cancer therapy.